Neoantigens
Neoantigens: are antigens encoded by tumor-specific mutated genes. Studies in the past few years have suggested a key role for neoantigens in cancer immunotherapy.
What's Popular in Neoantigens
C.E. CREDITS
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
FEB 22, 2018
6:00 AM PST
FEB 22, 2018
6:00 AM PST
Vaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
FEB 22, 2018
6:00 AM PST
FEB 22, 2018
6:00 AM PST
Vaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...
